Evidence map›Paper›PMID 29667016›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2018

Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices.

Daniele Pastori, Kazuo Miyazawa, Yanguang Li, Farhan Shahid, Hussein Hado, Gregory Y H Lip

Open access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Association between atrial fibrillation and Helicobacter pylori.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  2. Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Atrial high-rate episodes intensify RScientific reports · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Daniele PastoriInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Kazuo MiyazawaInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Yanguang LiInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Farhan ShahidInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Hussein HadoCardiology Department, City Hospital, Birmingham, B18 7QH, UK.
Gregory Y H LipInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. g.y.h.lip@bham.ac.uk.
University of Birmingham · GBBirmingham City Hospital · GBChinese PLA General Hospital · CNSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAtrial high-rate episodes (AHREs) are associated with an increased risk of developing atrial fibrillation and thromboembolism. The characteristics of 'real world' patients developing AHREs are poorly known.

methodsWe included 496 consecutive patients with cardiac implantable electronic devices (CIEDs). Primary endpoint was occurrence of AHREs, defined as > 175 bpm and lasting > 5 min, in a median follow-up of 16.5 (IQR 3.9-38.6) months (1082.4 patient-years). We also tested the predictive value of clinical risk scores for AHREs.

resultsMean age was 68.8 ± 14.0 years, and 35.5% were women; AHREs were recorded in 173 patients [34.7%, 16.0%/year, 95% confidence interval (CI) 13.7-18.6]. Multivariable Cox regression analysis showed that age [hazard ratio (HR) 1.020, 95% CI 1.004-1.035, p = 0.011], prior AF (HR 3.521, 95% CI 2.831-5.206, p < 0.001), white cell count (HR 1.039, 95% CI 1.007-1.072, p = 0.016) and high C reactive protein (CRP; HR 1.039, 95% CI 1.021-2.056, p = 0.038) were independently associated with AHREs. ROC curve analysis showed that the APPLE score (C statistic 0.53, 95% CI 0.48-0.59; p = 0.296) ALARMEc score (C statistic 0.51, 95% CI 0.44-0.57; p = 0.810) were non-significantly associated with AHRE. Similar results were obtained for CHADS

Indexed as

AlgorithmsForecastingAgedAtrial FibrillationDefibrillators, ImplantableFemaleFollow-Up StudiesGermanyHumansIncidenceInflammationMaleMiddle AgedPacemaker, ArtificialRetrospective StudiesRisk FactorsAHREsAtrial fibrillationImplantable deviceInflammationPacemaker

Identifiers

PMID29667016
PMCPMC6105258
OpenAlexW2802606084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.